(Q57003594)
Statements
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design (English)
George Kontopidis
Campbell McInnes
Iain McNae
Darren Gibson
Mokdad Mezna
Mark Thomas
Gavin Wood
Shudong Wang
Sravan R Pandalaneni
1 February 2006